Ana O. Hoff
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 1%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- Cancer-related Molecular Pathways
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 49
- Surgery 23
- Adrenal and Paraganglionic Tumors 12
- Thyroid and Parathyroid Surgery 6
- Co-authors
- Robert F. Gagel (19 shared papers)Steven I. Sherman (18 shared papers)Bruce Robinson (14 shared papers)Marcia S. Brose (13 shared papers)Makoto Tahara (12 shared papers)Corina E. Dutcus (10 shared papers)Naomi Kiyota (9 shared papers)Lori J. Wirth (11 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Thyroid (7 papers)Annals of Oncology (5 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)Cancer (4 papers)
- Partner nations
- BrazilUnited StatesAustralia
In The Last Decade
Ana O. Hoff
95 papers receiving 4.6k citations
Ana O. Hoff's Hit Papers
Peers
Comparison fields: 5 of 110
- Endocrinology, Diabetes and Metabolism 2.2k
- Oncology 1.7k
- Orthopedics and Sports Medicine 471
- Cancer Research 252
- Surgery 603
Countries citing papers authored by Ana O. Hoff
This map shows the geographic impact of Ana O. Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana O. Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana O. Hoff more than expected).
Fields of papers citing papers by Ana O. Hoff
This network shows the impact of papers produced by Ana O. Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana O. Hoff. The network helps show where Ana O. Hoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana O. Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer Hit paper breakdown → | 2015 | 1439 |
| 2 | 2008 | 488 | |
| 3 | 2006 | 261 | |
| 4 | 2005 | 190 | |
| 5 | 2021 | 162 | |
| 6 | 2003 | 141 | |
| 7 | 2017 | 130 | |
| 8 | 2002 | 130 | |
| 9 | 2001 | 125 | |
| 10 | 2006 | 113 | |
| 11 | 2006 | 107 | |
| 12 | 2004 | 84 | |
| 13 | 2010 | 75 | |
| 14 | 2000 | 70 | |
| 15 | 1998 | 64 | |
| 16 | 2008 | 59 | |
| 17 | 2016 | 48 | |
| 18 | 2007 | 41 | |
| 19 | 2022 | 38 | |
| 20 | 2021 | 37 |
About Ana O. Hoff
Ana O. Hoff is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Oncology, Epidemiology and Molecular Biology, having authored 105 papers that have together received 4.7k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (49 papers), Bone health and treatments (12 papers), Adrenal and Paraganglionic Tumors (12 papers), Neuroendocrine Tumor Research Advances (12 papers), Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Thyroid and Parathyroid Surgery (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Oncology (1.7k citations), Orthopedics and Sports Medicine (471 citations), Cancer Research (252 citations) and Surgery (603 citations). Ana O. Hoff has collaborated with scholars based in Brazil, United States and Australia. Frequent co-authors include Robert F. Gagel, Steven I. Sherman, Bruce Robinson, Marcia S. Brose, Makoto Tahara, Corina E. Dutcus, Naomi Kiyota, Lori J. Wirth, Gilbert J. Cote and Manisha H. Shah. Their work appears in journals such as Journal of Clinical Oncology, Thyroid, Annals of Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.